SynthesisExpert review of clinical pharmacology2020

Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook.

Patrick C Gedeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.